Would you please address the dangers of untreated sleep apnea? Also, what do people do when they are unable to tolerate a ...

Aliso Viejo-based Apnea Sciences bought an industrial building in Irvine for $2.6 million. The 5,101 square foot building at 12 Mauchly, Suite A, was sold in mid-December by an unnamed family trust, ...

The Food and Drug Administration (FDA) on Dec. 20 approved the obesity medication Zepbound (tirzepatide) as the first pharmaceutical treatment for moderate-to-severe obstructive sleep apnea (OSA) in ...

He’s already started to chip away at what once was with a series of billboards posted in major cities across the world that read: “The End Is Near ... Woe is me in my gilded cage, right?

The U.S. Food and Drug Administration (FDA) has granted approval for Zepbound, a weight-loss medication, to treat moderate to severe obstructive sleep apnea (OSA) in individuals with obesity.

Inspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary ...

Nyxoah's Genio implant is poised to revolutionize Obstructive Sleep Apnea treatment ... which offers a less intrusive alternative to CPAP and Inspire Therapy. Despite a high burn rate, Nyxoah ...

(Getty Images) (NewsNation) — Zepbound became the first drug approved by the Food and Drug Administration to treat obstructive sleep apnea in obese adults earlier this month. “This is a major step ...

Inspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s ...